Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab

Southern Medical Journal

Volumn 100, Issue 5, 2007, Pages 517-518

  Dweik, Mahmood ^a   Baethge, Bruce A ^a   Duarte, Alexander G ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Coccidiomycosis; Infliximab; Pneumonia; Rheumatoid arthritis; Tumor necrosis factor inhibitor

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; INFLIXIMAB; ITRACONAZOLE; METHOTREXATE; PREDNISONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION BIOPSY; BRONCHOSCOPY; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; DUST; HUMAN; LUMBAR PUNCTURE; LUNG LAVAGE; LUNG MYCOSIS; LYMPHADENOPATHY; MALE; RHEUMATOID ARTHRITIS; ROCK; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COCCIDIOIDOMYCOSIS; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PNEUMONIA;

EID: 34248195598     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000242797.49218.44     Document Type: Article

References (9)

1. Triggiani M, Granata F, Giannattasio G, et al. Lung involvement in rheumatoid arthritis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:171-179.
2. Liang GC, Cordero M, Dyer A, et al. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis. J Rheumatol 2005;32:1662-1665.
3. Hamilton CD. Immunosuppression related to collagen-vascular disease or its treatment. Proc Am Thorac Soc 2005;2:456-460.
4. Hochberg MC, Lebwohl MG, Plevy SE, et al. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 2005;34:819-836.
5. Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 2003;167:1279-1282.
6. Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum 2004;50:1959-1966.
7. Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am 2003;17:41-57.
8. Desai SA, Minai OA, Gordon SM, et al. Coccidioidomycosis in nonendemic areas: a case series. Resp Med 2001;95:305-309.
9. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-1772.